FMNL1 and nasopharyngeal carcinoma: To date, investigations on the role of FMNL1 in solid cancers, such as ccRCC, lung cancer and nasopharyngeal carcinoma, indicate FMNL1 as a promising prognostic marker to predict the outcomes of cancer patients.